Skip to main content

RESEARCH FOUNDATION

From fragmented evidence
to a decision-ready question.

CBCIA is a conceptual research framework for organizing fragmented clinical evidence into coherent, source-aware, decision-specific preparation for clinician review.

CONCEPTUAL FRAMEWORKRelated to, distinct from, the commercial product

01 / THE FRAMEWORK AT A GLANCE

The question is clinical.
The evidence is fragmented.

Records may be spread across documents, providers, languages and care settings. The objective is to reconstruct relevant evidence into clinical context, with source relationships and uncertainty intact, so the case is better prepared for clinician review.

CBCIA conceptual pathway: fragmented source evidence leads to decision-relevant uncertainty, intelligence reconstruction, decision-specific readiness and accountable clinical judgment. Source relationships, chronology, conflicts, missing evidence and open questions remain visible. Clinical judgment remains with the authorized clinician.
CBCIA conceptual framework: from fragmented evidence to source-aware, decision-specific clinical preparation.View full size

This visual describes a conceptual preparation pathway. Reconstructed context remains distinct from clinician interpretation.

02 / KEY PRINCIPLES

What the preparation must preserve.

SOURCE → CONTEXT → QUESTION

Make the evidence
reviewable.

The framework asks what is known, what remains unresolved and what the clinical question still requires.

EVIDENCE PREPARATION / CLINICAL AUTHORITY
  1. 01

    Source-linked context

    Evidence remains connected to its originating records. Provenance and chronology stay visible.

    SOURCE ↔ CONTEXT
  2. 02

    Explicit uncertainty

    Missing, conflicting or unresolved information remains visible rather than being silently flattened.

    ? / UNRESOLVED
  3. 03

    Decision alignment

    Relevant evidence is reconstructed around the clinical question being reviewed.

    DEFINED QUESTION
  4. 04

    Decision-specific readiness

    The case is organized around what is known, uncertain, missing and still required for review.

    OPEN REQUIREMENTS
  5. 05

    Clinician review boundary

    Interpretation and accountable clinical judgment remain with the authorized clinician.

    CLINICAL AUTHORITY

03 / A DIFFERENT ORIENTATION

A summary compresses records.
Clinical preparation connects them.

Summarization can make documents easier to read. CBCIA focuses on a further question: what does this evidence support, what remains unresolved, and what does the clinical decision still require?

Document summarization alone and source-aware clinical preparation: a comparison of focus, not a benchmark of specific tools.
Review dimensionDocument summary focusCBCIA conceptual orientation
Source relationshipsCompress records into a shorter account; provenance may become detached.Retain source links, chronology and the original evidence context.
Clinical contextCondense document contents; relevant and incidental findings may remain mixed.Reconstruct relevant evidence around the clinical question.
UncertaintyCompression may flatten conflict, missing information or ambiguity.Keep conflicts, gaps and unresolved questions explicit.
Decision requirementsProvide a general account without specifying what a decision still needs.Organize what is known, uncertain, missing and still required for review.
Clinical authorityA document output may leave the review stage undefined.Preserve an explicit authorized clinician review boundary.

04 / RESEARCH & PRODUCT

Related thinking.
Distinct roles.

CBCIA / CONCEPTUAL RESEARCH

A framework for the problem.

CBCIA explores evidence reconstruction, decision-specific readiness and accountable clinical judgment. It informs the architecture, product thinking and design of Krinex Clinical.

KRINEX CLINICAL / COMMERCIAL PRODUCT

A practical workflow.

The platform applies these ideas to evidence preparation and clinician review. The conceptual framework and the commercial product are related, but distinct.

Explore Krinex Clinical
CONCEPTUAL BASIS ≠ PRODUCT VALIDATION

CBCIA does not establish clinical validation or prove product effectiveness. It should not be interpreted as scientific proof of clinical performance.

AI assists evidence preparation. Clinical judgment remains with the authorized clinician.

CONTINUE THE CONVERSATION

Discuss the clinical question.
Explore the preparation it requires.

Discuss a clinical workflow or explore how these ideas inform Krinex Clinical.

Explore Krinex Clinical

KRINEX CLINICAL

Request a Demo

Tell us about the clinical workflow you would like to explore.

This page prepares a request for you to copy. It does not send or store your details.